Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Ticker
ABT
Exchange
NYSE
Sector
Healthcare
Industry
Medical Devices
Market cap
$186.10B
52-week range
$81.97 - $132.03

Valuation

Share price
$107.45 (close of Nov 16, 2026)
P/E (TTM)
39.94x
Price to book
3.60x
Price to free cash flow
27.54x
Enterprise value
$212.96B
Book value per share
$29.81

Price performance

PeriodChange
1 day-0.99%
5 days-2.77%
1 month+2.44%
3 months-3.42%
6 months+27.20%
Year to date-14.24%
1 year-17.72%
3 years+7.17%
5 years-17.91%
10 years+168.96%
All time+21,325.47%

Short interest

As of
Oct 30, 2026
Short % of float
1.23%
Shares short
19.06M
Days to cover
1.91
Change since prior report
+9.61%
Source
FINRA consolidated short interest

Members of Congress who disclosed ABT trades

Gilbert Ray Cisneros · Josh Gottheimer · Richard McCormick · Byron Donalds · Julie Johnson · Thomas Kean · Jared Moskowitz · Bruce Westerman · Julia Letlow · Lisa McClain · Rick Allen · Rick Larsen

And 8 others

Super investors holding ABT

Ken Griffin (Citadel) · Mason Hawkins (Southeastern Asset Management) · Mairs & Power (Mairs & Power Inc) · Ray Dalio (Bridgewater Associates) · David Katz (Matrix Asset Advisors Inc) · George Soros (Soros Fund Mgmt) · Dodge & Cox (Dodge & Cox Funds) · Thomas Russo (Gardner Russo & Quinn LLC) · Polen Capital Mgmt (Polen Capital Management LLC)

Profitability and growth

Return on equity
12.36%
Return on invested capital
9.17%
Return on assets
7.52%
Return on capital employed
11.47%
Gross margin
56.42%
Net margin
14.72%
EBITDA margin
25.20%
Revenue growth
5.67%
Net income growth
-51.32%
Free cash flow growth
16.44%

Cash flow and balance sheet

Free cash flow yield (TTM)
3.63%
Current ratio
1.45x
Net debt to EBITDA
2.53x

Latest reported year

Period end
Dec 31, 2025
Fiscal year
2025
Revenue
$44.33B
Cost of revenue
$19.32B
Gross profit
$25.01B
EBITDA
$11.17B
Net income
$6.52B
Earnings per share
$3.73
Research and development
$2.94B
Interest expense
$493.00M
Shares outstanding
1.74B

Income statement by year

Period endRevenueGross profitNet incomeEPS
2025-12-31$44.33B$25.01B$6.52B$3.73
2024-12-31$41.95B$23.24B$13.40B$7.67
2023-12-31$40.11B$22.13B$5.72B$3.28
2022-12-31$43.65B$24.51B$6.93B$3.94
2021-12-31$43.08B$24.54B$7.07B$3.97
2020-12-31$34.61B$19.61B$4.50B$2.52
2019-12-31$31.90B$18.67B$3.69B$2.07
2018-12-31$30.58B$17.87B$2.37B$1.34
2017-12-31$27.39B$14.98B$477.00M$0.27
2016-12-31$20.85B$11.76B$1.40B$0.94

Margins and returns by year

Period endGross marginNet marginReturn on equityReturn on capital
2025-12-3156.42%14.72%12.36%9.17%
2024-12-3155.41%31.95%27.98%10.85%
2023-12-3155.18%14.27%14.74%10.17%
2022-12-3156.15%15.88%18.79%12.80%
2021-12-3156.97%16.42%19.63%13.18%
2020-12-3156.65%12.99%13.62%9.19%
2019-12-3158.53%11.56%11.78%8.22%
2018-12-3158.45%7.74%7.71%6.19%
2017-12-3154.70%1.74%1.53%1.32%
2016-12-3156.39%6.71%6.76%6.26%

Cash and debt by year

Period endCashDebt
2025-12-31$8.94B$9.90B
2024-12-31$7.97B$12.63B
2023-12-31$7.28B$13.60B
2022-12-31$10.17B$14.52B
2021-12-31$10.25B$17.30B
2020-12-31$7.15B$18.53B
2019-12-31$4.14B$16.66B
2018-12-31$4.09B$19.36B
2017-12-31$9.61B$27.21B
2016-12-31$18.77B$20.68B

Free cash flow by year

Period endFree cash flowStock-based compensation
2025-12-31$7.39B$664.00M
2024-12-31$6.35B$673.00M
2023-12-31$5.06B$644.00M
2022-12-31$7.80B$685.00M
2021-12-31$8.65B$640.00M
2020-12-31$5.72B$546.00M
2019-12-31$4.50B$519.00M
2018-12-31$4.91B$477.00M
2017-12-31$4.43B$406.00M
2016-12-31$2.08B$310.00M

Dividend history

Most recent payment
Oct 15, 2026
Paid in the last twelve months
$2.52
Payment dateDividend per share
2026-10-15$0.63
2026-07-15$0.63
2026-04-15$0.63
2026-01-15$0.63
2025-10-15$0.59
2025-07-15$0.59
2025-04-15$0.59
2025-01-15$0.59

Investor relations

Past earnings dates

ReportedFiscal periodEPS estimate
2026-10-21Sep 2026$1.43
2026-07-16Jun 2026$1.28
2026-04-16Mar 2026$1.14
2026-01-22Dec 2025$1.50
2025-10-15Sep 2025$1.30
2025-07-17Jun 2025$1.25
2025-04-16Mar 2025$1.07
2025-01-22Dec 2024$1.34

Filings and sources

Company website
abbott.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Medtronic plc (MDT) · Stryker Corp (SYK) · Boston Scientific Corp (BSX) · Edwards Lifesciences Corp (EW) · GE HealthCare Technologies Inc. (GEHC) · Dexcom Inc (DXCM) · STERIS plc (STE) · Zimmer Biomet Holdings, Inc. (ZBH)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades